Posted inNews and Updates
First China-Approved CAR-T Therapy for Solid Tumors
A historic CAR-T approval for solid tumors and a $10B Pfizer-Innovent pact signal a new era of global oncology innovation and strategic biopharma growth.
Posted inNews and Updates
EU Regulators Recommend Jaypirca for Chronic Leukemia
The CHMP has recommended the approval of Jaypirca (pirtobrutinib) for adults with chronic lymphocytic leukemia. Learn about this new BTK inhibitor therapy.
Posted inNews and Updates
Glaukos Hits Key Milestone in Phase II GLK-321 Eye Trial
Glaukos has completed patient enrollment for its Phase II clinical trial of GLK-321, marking a key milestone in developing new ophthalmic therapies.
Posted inNews and Updates
Generative AI in Primary Care: Does It Improve Outcomes?
New research explores the impact of Generative AI in primary care. Can AI-driven decision support improve patient outcomes and clinical efficiency?
Posted inNews and Updates
Bonsai Biotherapeutics Secures Green Light for Clinical Trial
Bonsai Biotherapeutics, backed by Flerie, has received clinical trial approval to advance its therapeutic pipeline into human safety and efficacy testing.
Posted inNews and Updates
US FDA Grants Tentative Approval to Lupin’s Enzalutamide
Lupin receives tentative US FDA approval for Enzalutamide tablets, a key treatment for prostate cancer. Learn what this means for oncology patients.
Posted inNews and Updates
ProQR Reports Positive AX-0810 Phase 1 Trial Results
ProQR’s AX-0810 shows promising Phase 1 results, confirming target engagement for treating cholestatic diseases. Learn about the trial's latest impact.
Posted inNews and Updates
Zydus Lifesciences Enters Sri Lanka With New Pharma Venture
Zydus Lifesciences and Sunshine Holdings have launched a new joint venture to boost pharmaceutical access and medical supply chain efficiency in Sri Lanka.
Posted inNews and Updates
New AI-Driven Smart Cities Pilot to Support Vulnerable Groups
A new clinical trial tests AI-run smart microcities to improve health outcomes for veterans and the homeless through predictive care and automated support.
Posted inNews and Updates
Fosun Pharma Targets Alzheimer’s in Major Global Expansion
Fosun Pharma is pivoting toward Alzheimer’s research, diversifying its global pipeline beyond oncology to target major breakthroughs in neurodegeneration.